Evidence map›Paper›PMID 38270687›Full record

ArticleJournal of clinical immunology2024

A Novel Homozygous Germline Mutation in Transferrin Receptor 1 (TfR1) Leads to Combined Immunodeficiency and Provides New Insights into Iron-Immunity Axis.

Ümran Aba, İbrahim Cemal Maslak, Canberk İpşir, Damla Pehlivan, Nicholas I Warnock, Damon J Tumes, Gökhan Cildir, Baran Erman

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Iron and the immune system.Nature reviews. Immunology · 2025
    Review
  11. Review
  12. Article
  13. Why cells need iron: a compendium of iron utilisation.Trends in endocrinology and metabolism: TEM · 2024
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Ümran Aba *Department of Pediatric Immunology, Institute of Child Health, Hacettepe University, Ankara, Türkiye.ORCID 0000-0001-9458-3953
İbrahim Cemal Maslak *Division of Pediatric Allergy and Immunology, Süleyman Demirel University, Isparta, Türkiye.ORCID 0000-0001-9708-5490
Canberk İpşirDepartment of Pediatric Immunology, Institute of Child Health, Hacettepe University, Ankara, Türkiye.ORCID 0000-0003-0726-5004
Damla PehlivanCan Sucak Research Laboratory for Translational Immunology, Hacettepe University, Ankara, Türkiye.ORCID 0009-0004-2305-210X
Nicholas I WarnockCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, 5000, Australia.ORCID 0000-0003-3422-3184
Damon J TumesCentre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, 5000, Australia.ORCID 0000-0001-5709-857X
Gökhan Cildir *Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, 5000, Australia. Gokhan.Cildir@unisa.edu.au.ORCID 0000-0001-7457-9164
Baran Erman *Can Sucak Research Laboratory for Translational Immunology, Hacettepe University, Ankara, Türkiye. baranerman@gmail.com.ORCID 0000-0001-9398-8465
Hacettepe University · TRSouth Australia Pathology · AUSuleyman Demirel University · KZ

Funding

Hacettepe Üniversitesi THD-2022-20180Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 121S667
6 · The paper itself

Abstract

A homozygous missense mutation in the transferrin receptor 1 (TfR1), also known as CD71, leads to a rare inborn error of immunity (IEI) characterized by the impaired lymphocyte activation and proliferation due to defective iron uptake of cells. However, only one causative mutation (c.58T > C, p.Y20H) in the TFRC gene coding for TfR1 has been reported so far. We herein identified a new disease-causing homozygous germline mutation in the TFRC gene (c.64C > T, p.R22W) (referred to as TfR1

Indexed as

Germ-Line MutationPrimary Immunodeficiency DiseasesAntigens, CDGene Expression ProfilingHumansIronReceptors, TransferrinAntigens, CDCD71 antigenIronReceptors, TransferrinCD71Combined immunodeficiencyironlow-density neutrophilsT cells

Identifiers

PMID38270687
PMCPMC10811203
OpenAlexW4391230284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.